Methods to explain the clinical significance of health status measures.

One can classify ways to establish the interpretability of quality-of-life measures as anchor based or distribution based. Anchor-based measures require an independent standard or anchor that is itself interpretable and at least moderately correlated with the instrument being explored. One can further classify anchor-based approaches into population-focused and individual-focused measures. Population-focused approaches are analogous to construct validation and rely on multiple anchors that frame an individual's response in terms of the entire population (eg, a group of patients with a score of 40 has a mortality of 20%). Anchors for population-based approaches include status on a single item, diagnosis, symptoms, disease severity, and response to treatment. Individual-focused approaches are analogous to criterion validation. These methods, which rely on a single anchor and establish a minimum important difference in change in score, require 2 steps. The first step establishes the smallest change in score that patients consider, on average, to be important (the minimum important difference). The second step estimates the proportion of patients who have achieved that minimum important difference. Anchors for the individual-focused approach include global ratings of change within patients and global ratings of differences between patients. Distribution-based methods rely on expressing an effect in terms of the underlying distribution of results. Investigators may express effects in terms of between-person standard deviation units, within-person standard deviation units, and the standard error of measurement. No single approach to interpretability is perfect. Use of multiple strategies is likely to enhance the interpretability of any particular instrument.

[1]  M. King The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30 , 1996, Quality of Life Research.

[2]  N. Santanello,et al.  Impact of the global on patient perceivable change in an asthma specific QOL questionnaire , 1996, Quality of Life Research.

[3]  G. Guyatt,et al.  Measuring quality of life in children with asthma , 1996, Quality of Life Research.

[4]  R. Epstein,et al.  Interpretation of quality of life changes , 1993, Quality of Life Research.

[5]  G. Guyatt,et al.  Relation of Distribution- and Anchor-Based Approaches in Interpretation of Changes in Health-Related Quality of Life , 2001, Medical care.

[6]  L. Irwig,et al.  Estimating the number needed to treat (NNT) index when the data are subject to error , 2001, Statistics in medicine.

[7]  E. Lydick Approaches to the interpretation of quality-of-life scales. , 2000, Medical care.

[8]  M. Testa,et al.  Interpretation of quality-of-life outcomes: issues that affect magnitude and meaning. , 2000, Medical care.

[9]  D. Osoba,et al.  Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  M. Ward,et al.  Identification of clinically important changes in health status using receiver operating characteristic curves. , 2000, Journal of clinical epidemiology.

[11]  F D Wolinsky,et al.  Identifying meaningful intra-individual change standards for health-related quality of life measures. , 2000, Journal of evaluation in clinical practice.

[12]  R. Brant,et al.  Examining the minimum important difference. , 1999, Statistics in medicine.

[13]  A. Feinstein Indexes of contrast and quantitative significance for comparisons of two groups. , 1999, Statistics in medicine.

[14]  V. Entwistle,et al.  Decision aids for patients facing health treatment or screening decisions: systematic review , 1999, BMJ.

[15]  W. Tierney,et al.  Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. , 1999, Journal of clinical epidemiology.

[16]  J Zhang,et al.  What are minimal important changes for asthma measures in a clinical trial? , 1999, The European respiratory journal.

[17]  P. Kendall,et al.  Normative comparisons for the evaluation of clinical significance. , 1999, Journal of consulting and clinical psychology.

[18]  D. Osoba,et al.  Health-related quality of life in men with metastatic prostate cancer treated with prednisone alone or mitoxantrone and prednisone. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  N. Jacobson,et al.  Methods for defining and determining the clinical significance of treatment effects: description, application, and alternatives. , 1999, Journal of consulting and clinical psychology.

[20]  G H Guyatt,et al.  Users' guides to the medical literature: XVI. How to use a treatment recommendation. Evidence-Based Medicine Working Group and the Cochrane Applicability Methods Working Group. , 1999, JAMA.

[21]  W M Tierney,et al.  Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. , 1999, Medical care.

[22]  G H Guyatt,et al.  Sensitivity to change of the Roland-Morris Back Pain Questionnaire: part 1. , 1998, Physical therapy.

[23]  G. Guyatt,et al.  Interpreting treatment effects in randomised trials , 1998, BMJ.

[24]  D. Osoba,et al.  Interpreting the significance of changes in health-related quality-of-life scores. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  D. Spiegelhalter,et al.  Setting the minimal metrically detectable change on disability rating scales. , 1997, Archives of physical medicine and rehabilitation.

[26]  G. Regehr,et al.  Methodological problems in the retrospective computation of responsiveness to change: the lesson of Cronbach. , 1997, Journal of clinical epidemiology.

[27]  G. Guyatt,et al.  Economic analysis of respiratory rehabilitation. , 1997, Chest.

[28]  D A Redelmeier,et al.  Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. , 1997, American journal of respiratory and critical care medicine.

[29]  G. Guyatt,et al.  On the debate over methods for estimating the clinically important difference. , 1996, Journal of clinical epidemiology.

[30]  G. Guyatt,et al.  Assessing the minimal important difference in symptoms: a comparison of two techniques. , 1996, Journal of clinical epidemiology.

[31]  G. Guyatt,et al.  Interpretation of rhinoconjunctivitis quality of life questionnaire data. , 1996, The Journal of allergy and clinical immunology.

[32]  M. Limburg,et al.  The clinical meaning of Rankin 'handicap' grades after stroke. , 1995, Stroke.

[33]  R. Deyo,et al.  The significance of treatment effects: the clinical perspective. , 1995, Medical care.

[34]  C. Naylor,et al.  Can there be a more patient-centred approach to determining clinically important effect sizes for randomized treatment trials? , 1994, Journal of clinical epidemiology.

[35]  B. Demichelis,et al.  Completeness of reporting trial results: effect on physicians' willingness to prescribe , 1994, The Lancet.

[36]  C. Naylor,et al.  Prescribing propensity , 1994, Journal of general internal medicine.

[37]  G H Guyatt,et al.  Determining a minimal important change in a disease-specific Quality of Life Questionnaire. , 1994, Journal of clinical epidemiology.

[38]  D. Redelmeier,et al.  Assessing the clinical importance of symptomatic improvements. An illustration in rheumatology. , 1993, Archives of internal medicine.

[39]  Gordon Guyatt,et al.  Measuring Health-Related Quality of Life , 1993, Annals of Internal Medicine.

[40]  N. Hollenberg,et al.  Quality of Life and Antihypertensive Therapy in Men -- A Comparison of Captopril with Enalapril , 1993 .

[41]  C D Naylor,et al.  Measured Enthusiasm: Does the Method of Reporting Trial Results Alter Perceptions of Therapeutic Effectiveness? , 1992, Annals of Internal Medicine.

[42]  R. Kravitz,et al.  Differences in the mix of patients among medical specialties and systems of care. Results from the medical outcomes study. , 1992, JAMA.

[43]  F A Neelon,et al.  The Impact of Psychologic Factors on Measurement of Functional Status: Assessment of the Sickness Impact Profile , 1990, Medical care.

[44]  D A Redelmeier,et al.  Discrepancy between medical decisions for individual patients and for groups. , 1990, The New England journal of medicine.

[45]  G. Guyatt,et al.  Measurement of health status. Ascertaining the minimal clinically important difference. , 1989, Controlled clinical trials.

[46]  Lewis E. Kazis,et al.  Effect Sizes for Interpreting Changes in Health Status , 1989, Medical care.

[47]  C. Bulpitt,et al.  QUALITY OF LIFE ON ANGINA THERAPY: A RANDOMISED CONTROLLED TRIAL OF TRANSDERMAL GLYCERYL TRINITRATE AGAINST PLACEBO , 1988, The Lancet.

[48]  H. C. Hutchings,et al.  The cost effectiveness of auranofin: results of a randomized clinical trial. , 1988, The Journal of rheumatology.

[49]  G. Guyatt,et al.  A measure of quality of life for clinical trials in chronic lung disease. , 1987, Thorax.

[50]  R A Deyo,et al.  Assessing the responsiveness of functional scales to clinical change: an analogy to diagnostic test performance. , 1986, Journal of chronic diseases.

[51]  E B Keeler,et al.  Does free care improve adults' health? Results from a randomized controlled trial. , 1983, The New England journal of medicine.

[52]  R. Deyo,et al.  Measuring Functional Outcomes in Chronic Disease: A Comparison of Traditional Scales and a Self- Administered Health Status Questionnaire in Patients With Rheumatoid Arthritis , 1983, Medical care.

[53]  E Shapiro,et al.  Self-rated health: a predictor of mortality among the elderly. , 1982, American journal of public health.

[54]  R. Deyo,et al.  Physical and psychosocial function in rheumatoid arthritis. Clinical use of a self-administered health status instrument. , 1982, Archives of internal medicine.

[55]  I. Grant,et al.  Life quality of patients with chronic obstructive pulmonary disease. , 1982, Archives of internal medicine.

[56]  E F Cook,et al.  Comparative Reproducibility and Validity of Systems for Assessing Cardiovascular Functional Class: Advantages of a New Specific Activity Scale , 1981, Circulation.

[57]  M. Bergner,et al.  The Sickness Impact Profile: Development and Final Revision of a Health Status Measure , 1981, Medical care.

[58]  W. Best,et al.  The Crohn’s Disease Activity Index as a Clinical Instrument , 1981 .